Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Baxter
Citi
Cerilliant
Accenture
Covington
US Army
Chinese Patent Office
Healthtrust

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019500

« Back to Dashboard

NDA 019500 describes LAMPRENE, which is a drug marketed by Novartis and is included in one NDA. Additional details are available on the LAMPRENE profile page.

The generic ingredient in LAMPRENE is clofazimine. There are four drug master file entries for this compound. Additional details are available on the clofazimine profile page.
Summary for 019500
Tradename:LAMPRENE
Applicant:Novartis
Ingredient:clofazimine
Patents:0
Therapeutic Class:Antimycobacterials
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 019500

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength100MG
Approval Date:Dec 15, 1986TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength50MG
Approval Date:Dec 15, 1986TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Deloitte
Harvard Business School
US Department of Justice
Argus Health
Accenture
Cerilliant
UBS
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.